Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bonhoeffer

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Virology|August 8, 1998
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccineR I Connor, D C Montefiori, J M Binley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjectsG M Ortiz, M Wellons, J Brancato, et al.
AIDS (London, England)|June 21, 2001
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infectionF García, M Plana, G M Ortiz, et al.
Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.
Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.
The American Journal of the Medical Sciences|February 24, 1998
Resistance to antimicrobial chemotherapy: a prescription for research and actionB R Levin, R Antia, E Berliner, et al.
The Journal of Infectious Diseases|December 23, 1999
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfectionsX Jin, M A Demoitie, S M Donahoe, et al.
The Journal of Clinical Investigation|September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyG M Ortiz, D F Nixon, A Trkola, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Virology|August 8, 1998
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccineR I Connor, D C Montefiori, J M Binley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjectsG M Ortiz, M Wellons, J Brancato, et al.
AIDS (London, England)|June 21, 2001
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infectionF García, M Plana, G M Ortiz, et al.
Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.
Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.
The American Journal of the Medical Sciences|February 24, 1998
Resistance to antimicrobial chemotherapy: a prescription for research and actionB R Levin, R Antia, E Berliner, et al.
The Journal of Infectious Diseases|December 23, 1999
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfectionsX Jin, M A Demoitie, S M Donahoe, et al.
The Journal of Clinical Investigation|September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyG M Ortiz, D F Nixon, A Trkola, et al.
Pageof 5